Advertisement
Screener

IMMUNITYBIO, INC. (IBRX) Other than Temporary Impairment Losses, Investments

2.4 / 5 stars · 47/97 Roast Me

IMMUNITYBIO, INC. Other than Temporary Impairment Losses, Investments

IMMUNITYBIO, INC. (IBRX) reported Other than Temporary Impairment Losses, Investments of $0 for the 12-month period ending 2023-12-31, per its 10-K filed 2024-03-19.

Discontinued › Expense Statement › Operating Expenses

us-gaap:ImpairmentOfInvestments · last filed 2024-03-19

  • IMMUNITYBIO, INC. other than temporary impairment losses, investments for the quarter ending 2020-12-31 was $0.00.
  • IMMUNITYBIO, INC. other than temporary impairment losses, investments for the quarter ending 2020-09-30 was $0.00.
  • IMMUNITYBIO, INC. other than temporary impairment losses, investments for the quarter ending 2020-06-30 was $0.00.
  • IMMUNITYBIO, INC. other than temporary impairment losses, investments for the quarter ending 2020-03-31 was $0.00.
  • IMMUNITYBIO, INC. other than temporary impairment losses, investments for fiscal 2023 was $0.00.
  • IMMUNITYBIO, INC. other than temporary impairment losses, investments for fiscal 2022 was $0.00.
  • IMMUNITYBIO, INC. other than temporary impairment losses, investments for fiscal 2021 was $0.00.
  • IMMUNITYBIO, INC. other than temporary impairment losses, investments for fiscal 2020 was $0.00.
Period endOther than Temporary Impairment Losses, Investments 3 monthOther than Temporary Impairment Losses, Investments 6 monthOther than Temporary Impairment Losses, Investments 9 monthOther than Temporary Impairment Losses, Investments 12 month
2023-12-31$0.00
10-K · filed 2024-03-19
2022-12-31$0.00
10-K · filed 2024-03-19
2021-12-31$0.00
10-K · filed 2024-03-19
2020-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-01
$0.00
derived: sum of 2 quarters · filed 2023-03-01
$0.00
derived: sum of 3 quarters · filed 2023-03-01
$0.00
10-K · filed 2023-03-01
2020-09-30$0.00
10-Q · filed 2020-11-09
$0.00
derived: sum of 2 quarters · filed 2020-11-09
$0.00
10-Q · filed 2020-11-09
$0.00
derived: sum of 4 quarters · filed 2022-03-01
2020-06-30$0.00
10-Q · filed 2020-08-07
$0.00
10-Q · filed 2020-08-07
$0.00
derived: sum of 3 quarters · filed 2022-03-01
$0.00
derived: sum of 4 quarters · filed 2022-03-01
2020-03-31$0.00
10-Q · filed 2020-05-11
$0.00
derived: sum of 2 quarters · filed 2022-03-01
$0.00
derived: sum of 3 quarters · filed 2022-03-01
$0.00
derived: sum of 4 quarters · filed 2022-03-01
2019-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-01
$0.00
derived: sum of 2 quarters · filed 2022-03-01
$0.00
derived: sum of 3 quarters · filed 2022-03-01
$0.00
10-K · filed 2022-03-01
2019-09-30$0.00
10-Q · filed 2020-11-09
$0.00
derived: sum of 2 quarters · filed 2020-11-09
$0.00
10-Q · filed 2020-11-09
$0.00
derived: sum of 4 quarters · filed 2021-03-04
2019-06-30$0.00
10-Q · filed 2020-08-07
$0.00
10-Q · filed 2020-08-07
$0.00
derived: sum of 3 quarters · filed 2021-03-04
$0.00
derived: sum of 4 quarters · filed 2021-03-04
2019-03-31$0.00
10-Q · filed 2020-05-11
$0.00
derived: sum of 2 quarters · filed 2021-03-04
$0.00
derived: sum of 3 quarters · filed 2021-03-04
$0.00
derived: sum of 4 quarters · filed 2021-03-04
2018-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-04
$0.00
derived: sum of 2 quarters · filed 2021-03-04
$0.00
derived: sum of 3 quarters · filed 2021-03-04
$0.00
10-K · filed 2021-03-04
2018-09-30$0.00
10-Q · filed 2019-11-05
$0.00
derived: sum of 2 quarters · filed 2019-11-05
$0.00
10-Q · filed 2019-11-05
$0.00
derived: sum of 4 quarters · filed 2020-03-25
2018-06-30$0.00
10-Q · filed 2019-08-06
$0.00
10-Q · filed 2019-08-06
$0.00
derived: sum of 3 quarters · filed 2020-03-25
$0.00
derived: sum of 4 quarters · filed 2020-03-25
2018-03-31$0.00
10-Q · filed 2019-05-08
$0.00
derived: sum of 2 quarters · filed 2020-03-25
$0.00
derived: sum of 3 quarters · filed 2020-03-25
$0.00
derived: sum of 4 quarters · filed 2020-03-25
2017-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-25
$0.00
derived: sum of 2 quarters · filed 2020-03-25
$0.00
derived: sum of 3 quarters · filed 2020-03-25
$0.00
10-K · filed 2020-03-25
2017-09-30$0.00
10-Q · filed 2018-11-07
$0.00
derived: sum of 2 quarters · filed 2018-11-07
$0.00
10-Q · filed 2018-11-07
$0.00
derived: sum of 4 quarters · filed 2019-03-13
2017-06-30$0.00
10-Q · filed 2018-08-06
$0.00
10-Q · filed 2018-08-06
$0.00
derived: sum of 3 quarters · filed 2019-03-13
$0.00
derived: sum of 4 quarters · filed 2019-03-13
2017-03-31$0.00
10-Q · filed 2018-05-07
$0.00
derived: sum of 2 quarters · filed 2019-03-13
$0.00
derived: sum of 3 quarters · filed 2019-03-13
$0.00
derived: sum of 4 quarters · filed 2019-03-13
2016-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-13
$0.00
derived: sum of 2 quarters · filed 2019-03-13
$0.00
derived: sum of 3 quarters · filed 2019-03-13
$0.00
10-K · filed 2019-03-13
2016-09-30$0.00
10-Q · filed 2016-11-10
$0.00
derived: sum of 2 quarters · filed 2016-11-10
$0.00
10-Q · filed 2017-11-07
$0.00
derived: sum of 4 quarters · filed 2018-03-12
2016-06-30$0.00
10-Q · filed 2016-08-15
$0.00
10-Q · filed 2017-08-07
$0.00
derived: sum of 3 quarters · filed 2018-03-12
$0.00
derived: sum of 4 quarters · filed 2018-03-12
2016-03-31$0.00
10-Q · filed 2017-05-08
$0.00
derived: sum of 2 quarters · filed 2018-03-12
$0.00
derived: sum of 3 quarters · filed 2018-03-12
$0.00
derived: sum of 4 quarters · filed 2018-03-12
2015-12-31$0.00
derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-12
$0.00
derived: sum of 2 quarters · filed 2018-03-12
$0.00
derived: sum of 3 quarters · filed 2018-03-12
$0.00
10-K · filed 2018-03-12
2015-09-30$0.00
10-Q · filed 2016-11-10
$0.00
derived: sum of 2 quarters · filed 2016-11-10
$0.00
10-Q · filed 2016-11-10
2015-06-30$0.00
10-Q · filed 2016-08-15
$0.00
10-Q · filed 2016-08-15
2015-03-31$0.00
10-Q · filed 2016-05-16
2014-12-31$0.00
10-K · filed 2017-03-15
2013-12-31$0.00
10-K · filed 2016-03-30

Similar stocks

Stock NameCountryMarket CapPE Ratio
Kymera Therapeutics, Inc. (KYMR)United States$9.631B-31.69
Vaxcyte, Inc. (PCVX)United States$8.466B-7.91
Krystal Biotech, Inc. (KRYS)United States$10.210B45.56
REPLIGEN CORP (RGEN)United States$10.755B185.31
Immunovant, Inc. (IMVT)United States$7.028B-14.78
BIO-TECHNE Corp (TECH)United States$11.379B74.68
Twist Bioscience Corp (TWST)United States$11.540B-47.21
CG Oncology, Inc. (CGON)United States$6.095B-27.95
Scholar Rock Holding Corp (SRRK)United States$5.920B-16.37
CRISPR Therapeutics AG (CRSP)$5.390B-11.68